$0.3510
-0.00720-2.01%
At close: -
$0.3206
-0.03-8.66%
After Hours: 9:21 AM EDT
Comments
Loading...
Co-Diagnostics Analyst Ratings and Price Targets | NASDAQ:CODX | Benzinga
Co-Diagnostics Inc has a consensus price target of $5.33 based on the ratings of 3 analysts. The high is $10 issued by D. Boral Capital on April 28, 2025. The low is $1 issued by HC Wainwright & Co. on March 28, 2025. The 3 most-recent analyst ratings were released by D. Boral Capital, HC Wainwright & Co., and HC Wainwright & Co. on April 28, 2025, March 28, 2025, and November 11, 2024, respectively. With an average price target of $4.17 between D. Boral Capital, HC Wainwright & Co., and HC Wainwright & Co., there's an implied 1199.65% upside for Co-Diagnostics Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
D. Boral Capital
HC Wainwright & Co.
Sidoti & Co.
1calculated from analyst ratings
Analyst Ratings for Co-Diagnostics
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 04/28/2025 | Buy Now | 3019.15% | D. Boral Capital | Jason Kolbert45% | → $10 | Initiates | → Buy | Get Alert |
| 03/28/2025 | Buy Now | 211.92% | HC Wainwright & Co. | Yi Chen57% | $1.5 → $1 | Maintains | Neutral | Get Alert |
| 11/11/2024 | Buy Now | 367.87% | HC Wainwright & Co. | Yi Chen57% | $1.5 → $1.5 | Reiterates | Neutral → Neutral | Get Alert |
| 08/12/2024 | Buy Now | 367.87% | HC Wainwright & Co. | Yi Chen57% | $2 → $1.5 | Maintains | Neutral | Get Alert |
| 06/17/2024 | Buy Now | 523.83% | HC Wainwright & Co. | Yi Chen57% | $2 → $2 | Reiterates | Neutral → Neutral | Get Alert |
| 05/13/2024 | Buy Now | 523.83% | HC Wainwright & Co. | Yi Chen57% | $2.5 → $2 | Maintains | Neutral | Get Alert |
| 03/15/2024 | Buy Now | 679.79% | HC Wainwright & Co. | Yi Chen57% | $3 → $2.5 | Maintains | Neutral | Get Alert |
| 12/29/2023 | Buy Now | 835.75% | HC Wainwright & Co. | Yi Chen57% | $3 → $3 | Reiterates | Neutral → Neutral | Get Alert |
| 11/13/2023 | Buy Now | 835.75% | HC Wainwright & Co. | Yi Chen57% | $2 → $3 | Maintains | Neutral | Get Alert |
| 08/14/2023 | Buy Now | 523.83% | HC Wainwright & Co. | Yi Chen57% | $3 → $2 | Maintains | Neutral | Get Alert |
| 05/15/2023 | Buy Now | 835.75% | HC Wainwright & Co. | Yi Chen57% | → $3 | Reiterates | Neutral → Neutral | Get Alert |
| 03/20/2023 | Buy Now | 835.75% | HC Wainwright & Co. | Yi Chen57% | $6 → $3 | Downgrade | Buy → Neutral | Get Alert |
| 02/23/2023 | Buy Now | 1771.49% | HC Wainwright & Co. | Yi Chen57% | → $6 | Reiterates | → Buy | Get Alert |
| 11/14/2022 | Buy Now | 1771.49% | HC Wainwright & Co. | Yi Chen57% | $9 → $6 | Maintains | Buy | Get Alert |
| 08/15/2022 | Buy Now | 2707.24% | HC Wainwright & Co. | Yi Chen57% | $12 → $9 | Maintains | Buy | Get Alert |
| 08/12/2022 | Buy Now | 1459.58% | Sidoti & Co. | James Sidoti65% | → $5 | Downgrade | Buy → Neutral | Get Alert |
| 05/16/2022 | Buy Now | 3642.98% | HC Wainwright & Co. | Yi Chen57% | $15 → $12 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Co-Diagnostics (CODX) stock?
The latest price target for Co-Diagnostics (NASDAQ:CODX) was reported by D. Boral Capital on April 28, 2025. The analyst firm set a price target for $10.00 expecting CODX to rise to within 12 months (a possible 3019.15% upside). 6 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Co-Diagnostics (CODX)?
The latest analyst rating for Co-Diagnostics (NASDAQ:CODX) was provided by D. Boral Capital, and Co-Diagnostics initiated their buy rating.
When was the last upgrade for Co-Diagnostics (CODX)?
There is no last upgrade for Co-Diagnostics
When was the last downgrade for Co-Diagnostics (CODX)?
The last downgrade for Co-Diagnostics Inc happened on March 20, 2023 when HC Wainwright & Co. changed their price target from $6 to $3 for Co-Diagnostics Inc.
When is the next analyst rating going to be posted or updated for Co-Diagnostics (CODX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Co-Diagnostics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Co-Diagnostics was filed on April 28, 2025 so you should expect the next rating to be made available sometime around April 28, 2026.
Is the Analyst Rating Co-Diagnostics (CODX) correct?
While ratings are subjective and will change, the latest Co-Diagnostics (CODX) rating was a initiated with a price target of $0.00 to $10.00. The current price Co-Diagnostics (CODX) is trading at is $0.32, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
